ICD-10 Code C93.02 | Acute monoblastic/monocytic leukemia, in relapse Symptoms, Diagnosis, Billing

Acute monoblastic/monocytic leukemia, in relapse is a hematological malignancy characterized by the proliferation of monoblasts and monocytic cells in the bone marrow and peripheral blood. This condition is clinically significant due to its aggressive nature and poor prognosis. Accurate coding with ICD-10 Code C93.02 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.

What is ICD-10 Code C93.02 for Acute monoblastic/monocytic leukemia, in relapse?

ICD-10 Code C93.02 represents Acute monoblastic/monocytic leukemia, in relapse, a subtype of acute myeloid leukemia. This code is used when a patient experiences a recurrence of the disease after a period of remission. It is crucial for clinical documentation and billing to accurately reflect the patient's condition and treatment needs, ensuring appropriate care and resource allocation.

ICD-10 Code C93.02 – Clinical Definition and Explanation of Acute monoblastic/monocytic leukemia, in relapse

Acute monoblastic/monocytic leukemia, in relapse is caused by genetic mutations leading to the uncontrolled proliferation of monoblasts and monocytic cells. The condition can progress rapidly, necessitating immediate medical intervention. Its aggressive nature and potential for complications underscore the importance of timely diagnosis and treatment.

Key Clinical Features:

• Rapid onset of symptoms including fatigue, fever, and bleeding.
• Presence of monocytic cells in peripheral blood and bone marrow.
• Increased risk of infections due to bone marrow infiltration.
• Potential for extramedullary disease manifestations.

ICD-10 Code C93.02 for Acute monoblastic/monocytic leukemia, in relapse – SOAP Notes & Clinical Use

ICD-10 Code C93.02 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plan. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management and ensuring accurate billing for services rendered.

What Does ICD-10 Code C93.02 for Acute monoblastic/monocytic leukemia, in relapse Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C93.02 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Acute monoblastic/monocytic leukemia, in relapse. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C93.02 – Acute monoblastic/monocytic leukemia, in relapse

Acute monoblastic/monocytic leukemia, in relapse requires urgent medical intervention, often necessitating hospitalization for intensive treatment.

Antibiotic Therapy:

• Ciprofloxacin 500 mg orally twice daily for 7-14 days.
• Piperacillin-tazobactam 3.375 g IV every 6 hours for 7-14 days.
• Vancomycin 1 g IV every 12 hours for 7-14 days.

Supportive Care:

• Transfusion of red blood cells and platelets as needed.
• Administration of growth factors such as G-CSF.
• Management of febrile neutropenia with appropriate antibiotics.

Infection Control:

• Implement strict hand hygiene protocols.
• Use of masks and isolation precautions for immunocompromised patients.
• Regular monitoring for signs of infection during treatment.

How to Document Symptoms of Acute monoblastic/monocytic leukemia, in relapse (ICD-10 C93.02) in SOAP Notes

Subjective:

• Patient reports increased fatigue and weakness.
• History of recurrent fevers and night sweats.
• Complaints of easy bruising and bleeding gums.
• Patient expresses concern about weight loss.

Objective:

• Vital signs: Temperature 101°F, heart rate 110 bpm.
• Physical exam reveals pallor and petechiae.
• Complete blood count shows leukocytosis and anemia.
• Bone marrow biopsy confirms presence of monoblasts.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Acute monoblastic/monocytic leukemia, in relapse (ICD-10 Code C93.02)

Assessment:

• Diagnosis: Acute monoblastic/monocytic leukemia, in relapse (ICD-10 Code C93.02).
• Severity: High due to rapid progression and complications.
• Triggers: Previous treatment history and genetic predisposition.
• Complications: Risk of infection and bleeding.

Plan:

• Initiate chemotherapy regimen as per protocol.
• Administer supportive care including transfusions.
• Monitor blood counts and clinical status closely.
• Schedule follow-up appointments for ongoing assessment.

Treatment & Plan Section for ICD-10 Code C93.02 – Acute monoblastic/monocytic leukemia, in relapse

• First-line pharmacologic treatments include cytarabine and anthracyclines.
• Non-pharmacologic strategies involve nutritional support and psychosocial counseling.
• Monitoring practices include regular CBC checks and clinical evaluations.
• Follow-up should be scheduled every 1-2 weeks during treatment.

Using ICD-10 Code C93.02 for Acute monoblastic/monocytic leukemia, in relapse in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code C93.02 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Acute monoblastic/monocytic leukemia, in relapse

• C93.01 – Acute monoblastic/monocytic leukemia, not in relapse
• C92.00 – Acute myeloid leukemia, unspecified
• C92.01 – Acute myeloid leukemia, in remission
• C94.00 – Other specified leukemias

ICD-10 Code C93.02 in Medical Billing and Insurance for Acute monoblastic/monocytic leukemia, in relapse

ICD-10 Code C93.02 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed patient history and treatment rationale.
• Use the code in conjunction with relevant CPT codes for comprehensive billing.
• Verify that all chart elements support the diagnosis for claim approval.

Common CPT Pairings: